Page 30 - 2021 Policy Watch

icy Watch: Brief Analysis of the Intellectual Property Sections of Three Influential International Trade Agreements and one Bilateral Trade Agreement

5.ä¸?????éª??§ä½¿??? Other use without autho-
Experimental use of a pat- rization of the right holder;
ent; 6.ä¸???³è?ï¼?
6.审æ???³¨???ç¨??äº? Patent filling;

项ï? 7.ä¿?????æ­£å???¿°??

Procedural aspects of ex- �?
amination and registra- Amendments, corrections
tion; and observations;

7.ä¸??宽é???? 8.ä¸???³è????å¸??

Grace period for patents; Publication of patent ap-
8.ä¸???µå??³è??¶åº¦ï¼? plications;
Electronic patent applica- 9.ä¸?·²???ä¸???³è???·²
tion system;
???ä¸???¸å???¿¡???

9.18�????� Information relating to

18-month publication; published patent applica-
10.?¨ä????ä¸????? tions and granted patents;

????????????ä¿? 10.???äº???³ä????

??? è¿?»¶????´ä??©æ?ï¼?

Information as prior art Patent term adjustment
made available to the pub- for unreasonable granting
lic on the Internet; authority delays;

11.å¿?????¥ï?

Expedited examination; ä¸??????³ç???? ?¸å????ä½??ETA?????

12.å¼???½é?ä¸????±» Measures relating to phar- ??
maceutical products
?¶åº¦ï¼? ä¸??

Introduction of interna- 11.??????缩ç???? ETA, Section D
tional patent classification ?´ä??©æ?ï¼? Patents
system; Patent term adjustment for ä¸????????延é?ï¼?
13.ä¿??æ¤???°å?ç§?? unreasonable curtailment Effective patent term ex-
Protection of new varieties 12.???审æ?ä¾??ï¼? tension;
of plants; Regulatory review excep-
tion;

13.ä¿??????²è?éª??

????¶ä??°æ?ï¼?

Protection of undisclosed
test or other data;

14.????¶å?ï¼?

Biologics;

15.?°è????å®??ï¼?

Definition of new pharma-
ceutical product;

16.�??????????

?³ç????ï¼?

Measures relating to the
marketing of certain phar-
maceutical products;

17.ä¿?????????´ï?

Alteration of period of
protection;

30